2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Wearable Integration in Symptom Evaluation for Cancer Survivorscancer, neoplasmEnrolling by invitationNot applicable2026-04-23NCT07463547
Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast CancerHER2 positive breast carcinoma, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 1 / Phase 22026-01-23NCT03368729